Belarus vs Morocco: HIV/AIDS deaths averted by antiretroviral therapy
Belarus
1,203 deaths
in 2022
Morocco
1,213 deaths
in 2024
Belarus rank
71st
Morocco rank
70th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Belarus
- Morocco
How they compare
Morocco currently reports 1,213 deaths against 1,203 deaths in Belarus, a difference of 10 deaths.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Morocco ahead.
Belarus ranks 71st and Morocco ranks 70th of 157 countries.
Across the 4 decades both report, Belarus averaged higher in 1 and Morocco in 2.
Head to head by decade
| Decade | Belarus | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 70.2 deaths | 183.06 deaths | 112.86 deaths | Morocco |
| 2010s | 703.4 deaths | 725.97 deaths | 22.57 deaths | Morocco |
| 2020s | 1,184 deaths | 1,032 deaths | 152.08 deaths | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Belarus or Morocco?
- Morocco, at 1,213 deaths against 1,203 deaths in Belarus as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Belarus and Morocco?
- 10 deaths, with Morocco ahead.
- How many years of comparable data are there for Belarus and Morocco?
- 33 years are reported by both, from 1990 to 2022.
- How do Belarus and Morocco rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Belarus ranks 71st and Morocco ranks 70th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.